Loading company details...
Latest Form 4 (Jul 17, 2026): James E. Flynn (Director): Disposition to Issuer of 8,299,225 shares, $1.03B.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 17, 2026 | James E. Flynn | Disposition to Issuer | 8,299,225 | $1.03B |
| Jul 15, 2026 | Michael L. Meyers | Tender of Shares | 5,146 | $638.1K |
| Jul 15, 2026 | Alexandra Balcom, Chief Financial Officer | Tender of Shares | 44,433 | $5.51M |
| Jul 15, 2026 | Sapna Srivastava | Tender of Shares | 5,146 | $638.1K |
| Jul 15, 2026 | Christy J. Oliger | Tender of Shares | 1,324 | $164.2K |
| Jul 15, 2026 | Ron Squarer | Disposition to Issuer | 6,281 | n/a |
| Jul 15, 2026 | Christopher Durant Turner, Chief Medical Officer | Tender of Shares | 31,530 | $3.91M |
| Jul 15, 2026 | Darlene Noci, Chief Development Officer | Tender of Shares | 17,017 | $2.11M |
| Jul 15, 2026 | Benjamin Lane, Chief Technical Operations Officer | Tender of Shares | 21,092 | $2.62M |
| Jul 15, 2026 | Henry E. Pelish, Chief Scientific Officer | Tender of Shares | 22,393 | $2.78M |